Chapter 65 Osteoporosis Q&A (1 of 59) Sample Questions
1. DM is a 76-year-old woman who was recently seen at an outpatient clinic following a fall. She was given a bone mineral density scan and was found to have a T-score at the spine of -1.8 and at the hip of -2.6. The physician at the clinic gives her a prescription for Alendronate 70 mg by mouth weekly, and she brings the prescription into the pharmacy. The pharmacist reviews DM's profile and sees that she is also taking Simvastatin, Lisinopril, Lansoprazole, and Calcium carbonate plus vitamin D. DM tells the pharmacist that she feels fine and does not understand why she should take this medication. She also asks if it is true that she has to stand up for 2 hours after she takes the Alendronate. What should the pharmacist tell the patient?
- A. Bisphosphonate increases bone mass and decreases risk of fracture
- B. Bisphosphonate increases bone mass decreases risk of fall
- C. Bisphosphonates are the first line therapy for osteoporosis prevention and treatment
- D. Bisphosphonate reduce risk of cancer